Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467298 · ClinicalTrials.gov registry record · NA
An Intervention to Improve Function in Severe Cardiopulmonary Illness
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT00467298: Completed NA study, sponsored by VA Office of Research and Development.
NCT00467298 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00467298, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The study is a randomized trial of a cardiopulmonary self-management intervention to improve functional capacity, health-related quality of life, and to reduce health care utilization. Two hundred (100 in each group) will be recruited from VA Puget Sound Health Care System over four years. Outcomes will be measured at three points: at entry, at the end of the 6 month intervention, and 12 months after entry. Change in functional capacity at the end of the intervention program is the primary outcome.
Primary Outcome
6MWT-Six Minute Walk Test
Interventions
- BEHAVIORAL Exercise adherence
- BEHAVIORAL Self-management- prevention of illness
- BEHAVIORAL Self-management of illness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2007-12 |
| Est. Completion | 2011-12 |
| Phase | NA |
What the finished NCT00467298 record still lists
NCT00467298 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Exercise adherence is the first listed.
NCT00467298 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00467298 about?
NCT00467298 is a clinical study titled "An Intervention to Improve Function in Severe Cardiopulmonary Illness". The study is a randomized trial of a cardiopulmonary self-management intervention to improve functional capacity, health-related quality of life, and to reduce health care utilization. Two hundred (100 in each group) will be recruited from VA Puget Sound Health Care System over four years. Outcomes ...
What is the current status of trial NCT00467298?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2007-12. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00467298?
The interventions under investigation include: Exercise adherence (BEHAVIORAL), Self-management- prevention of illness (BEHAVIORAL), Self-management of illness (BEHAVIORAL).
Who is sponsoring clinical trial NCT00467298?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00467298's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia